Bitespiramycin, a group of 4"-O-acylated spiramycins with 4"-O-isovalerylspiramycins as the major components, was produced by recombinant spiramycin-producing strain Streptomyces spiramyceticus harboring a 4"-O-acyltransferase gene. The experiment was initially performed in synthetic medium with 0.5 g l -1 Valine, Isoleucine or Leucine feeding at 36 h cultivation. When valine was fed, the biological titer of bitespiramycin was 45.3% higher than that of the control group, but the relative content of total isovalerylspiramycin components decreased by 22.5%. In the case of ilecine, the biological titer of bitespiramycin and the total isovalerylspiramycins alone were 85% and 72.1% of the control group, respectively. In contrast, the relative content of other acylated spiramycins increased by 54.41%.
INTRODUCTION
Bitespiramycin is a group of 4"-O-acylated spiramycins with 4"-O-isovalerylspiramycins as the major components (29) . Although bitespiramycin has similar antibiotic activity with spiramycin in vitro, the former has superior pharmacokinetic properties compared with spiramycin in vivo. These properties are: quick oral absorption, high tissue permeability, wide distribution in the body. Long in vivo half-life owing to its high lipophilicity. Bitespiramycin is mainly used for the treatment of Gram-positive bacteria infectious diseases, such as upper respiratory tract and urinary system infections (19, 20, 21) .
Bitespiramycin is produced by recombinant Streptomyces spiramyceticus F21 that harbores a 4"-O-acyltransferase gene from S. mycarofaciens 1748 (18) . There are a total of 14 components in bitespiramycin owing to the relatively broad substrate specificity of the acyltransferase (10) . Thus, during
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Biosythesis of bitespiramycin 4"-O-acylspiramycins the fermentation process of bitespiramycin, the enhancement of the biosynthesis of 4"-O-isovalerylspiramycins is a distinctly significant step, as these are the main components responsible for the new pharmacokinetic properties of bitespiramycin.
Amino acids can be used as carbon or nitrogen source in the fermentation of antibiotics. Some amino acids such as valine (Val), isoleucine (Ile) or leucine (Leu) are precursors of some secondary metabolites, and the metabolites derived from them such as acetyl-CoA, propionyl-CoA, isovalerylCoA and butyryl-CoA are precursors of the biosynthesis of macrolide antibiotics (the biosynthesis pathway of bitespiramycin is illustrated in Fig. 1 ) (8, 14, 17, 26, 28) . 
MATERIALS AND METHODS

Microorganism and cultivation conditions
In all the experiments, a gene-engineered strain WSJ- and the count was more than 5×10 6 spore ml -1 . For seed cultivation, one ml spore solution was inoculated into a primary 250-ml shake flask containing 50 ml seed medium.
After 48 h of incubation at 28, 10 ml of primary seed culture was inoculated into a secondary 500-ml shake flask containing 100 ml seed medium. After 24 h of incubation at 28, 4 ml of secondary seed culture was inoculated into a 500-ml fermentation flask containing 50 ml fermentation medium, which was shaken at 220 revolutions per minute and 28 for 96 h of fermentation.
For the feeding method of the three amino acids, 0.5 g l -1
Val, Leu or Ile was treated with ultraviolet radiation for 12 h, and then the sterilized Val, Leu or Ile was supplemented into different fermentation flasks to obtain the final defined concentration of each of the amino acids.
Feeding method of the Leu in the culture with complex medium: (1) 2.0 g l -1 Leu was supplemented at one time at 72 h of fermentation; (2) at 72 h of fermentation, a total of 2.0 g l -1 Leu was fed at an interval of 6h (72 h, 80 h and 90 h of fermentation).
Total sugar, ammonium ion, dry cell weight and the
biological titer determination
Total sugar concentrations in the medium were determined using dinitrosalicylic acid (DNS) method (15) .
The supernatant of the fermentation broth obtained after centrifugation was boiled with 6 N HCl for 10 min and neutralized by equal volumes of 6 N NaOH. The hydrolysate was analyzed using dinitrosalicylic acid (DNS) method. The ammonium ion in the defined medium was determined using a method described by Weatherburn (25) , while NH 2 -N in the complex medium was analyzed by Foreman's formaldehyde titration method. Determination of dry cell weight (DCW)
was performed using the method described by Lebrihi (12) .
Biological titer was estimated by the conventional disc method using Bacillus pumilus as test microorganism and acetylspiramycin as the standard (1).
Components and organic acids measurements by HPLC
The fermentation broth of bitespiramycin was 
Determination of intracellular pyruvate acid by HPLC
The mycelia were centrifuged at 4 and 4000 r min The supernatant was used for determining intracellular pyruvate acid. The measurement conditions for HPLC were the same as those for the extracellular acetic acid and propionic acid described above.
The activities of pyruvate carboxylase (PC) and citrate synthase (CS) measurement
The mycelia were collected by freeze centrifugation at 4
and 4000 r min The activities of PC and CS were measured according to the reference papers (6, 13) . One unit (U) of a specific enzyme was defined as 1 µmol of catalysate produced per min. The protein content was determined by Coomassie brilliant blue G250 staining method, and calculated according to the standard curve of bovine serum albumin.
RESULTS
The effects of Val, Ile or Leu on the yield and the composition of bitespiramycin
The supplementation of Val, Ile or Leu during the fermentation process of bitespiramycin influenced the growth of microorganism and the biosynthesis of bitespiramycin.
After supplementation with amino acids, the biomass was a little lower than that of the control group, the increase in the titer of bitespiramycin was nearly stopped (48 h), and the inter-group differences increased with the ongoing fermentation process. In the culture supplemented with Val, the titer of bitespiramycin increased significantly after 12 h adaptation, higher than that of the control group by 45.3% at the end of fermentation. As for Ile, the titer increased slowly, and towards the end of the fermentation process, was only 85% of the control group. For Leu, the titer of bitespiramycin was almost equal to that of the control group. After supplementation with Val, the relative content of spiramycins and butyrylspiramycin increased, the most apparent changes being the increase of the relative content of spiramycin I and spiramycin III. The relative contents of total isovalerylspiramycins and other acylated components decreased by 22.5% and 27.5% while the relative contents of total spiramycins increased by 54.5%, respectively. After supplementation with Ile, the glucose consumption rate was only 0.1-0.2 g l -1 h -1 , which was apparently lower than that of the control group, whereas after supplementation with Leu, the glucose consumption rate was 0.3-0.5 g l -1 h -1 , which was similar to that of the control group. It is obvious that the glucose consumption rate is closely correlated to the titer of bitespiramycin.
The effects of Val, Ile or Leu on glycometabolism
Biosythesis of bitespiramycin 4"-O-acylspiramycins
It is shown in Fig The microorganism has different utilization patterns for each of the three amino acids, resulting in different effects on glycometabolism. It was observed that the pH of the culture medium did not increase after supplementation with Val, while it was higher than that of the control group after supplementation with Leu or Ile, and the concentration of ammonium ion in the fermentation broth had a marked increase after supplementation with Ile or Leu (Fig. 3A) .
During the metabolism process of Leu and Ile, the amino group was excreted in the culture broth after deamination reaction, and the remaining carbon skeleton was directly used by the bacteria cells. However, after supplementation with
Val the concentration of ammonium ion in the fermentation broth became almost equal to that of the control group. A similar phenomenon was also observed by Voelker et al (23) .
They proposed that the amino group from the adsorbed Val was further used by mycerlia, and the remaining carbon skeleton, i.e., -ketoisovaleric acid, was temporarily excreted out and then re-adsorbed into the mycerlia for further use after the intracellular ammonium ions were exhausted. 
